In addition, serious questions were raised about the completeness and homogeneity of PV and other MPN cases reported to cancer registries, resulting in part from the recent addition of the JAK2 mutation to the diagnosis criteria. The gene discussed is JAK2; the disease is acquired polycythemia vera.